These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 31505158)

  • 21. Economic and safety benefits of pharmaceutical interventions by community and hospital pharmacists in Japan.
    Tasaka Y; Yasunaga D; Tanaka M; Tanaka A; Asakawa T; Horio I; Miyauchi Y; Araki H
    Int J Clin Pharm; 2016 Apr; 38(2):321-9. PubMed ID: 26744362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the economic and clinical impact of community pharmacist-driven pharmacy benefit management services.
    Jackson DL; Michaels NM; Melson B; Bruder E; Rhodes LA; Marciniak MW
    J Am Pharm Assoc (2003); 2019; 59(4S):S91-S94. PubMed ID: 31203015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacists' perceptions of pay for performance versus fee-for-service remuneration for the management of hypertension through pharmacist prescribing.
    Rosenthal MM; Desai N; Houle SKD
    Int J Pharm Pract; 2017 Oct; 25(5):388-393. PubMed ID: 28097711
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of prescription reimbursement methodologies in Japan and the United States.
    Akaho E; MacLaughlin EJ; Takeuchi Y
    J Am Pharm Assoc (2003); 2003; 43(4):519-26. PubMed ID: 12952317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Asheville Project: short-term outcomes of a community pharmacy diabetes care program.
    Cranor CW; Christensen DB
    J Am Pharm Assoc (Wash); 2003; 43(2):149-59. PubMed ID: 12688433
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The paradox of pharmacy: A profession's house divided.
    Brown D
    J Am Pharm Assoc (2003); 2012; 52(6):e139-43. PubMed ID: 23143300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Projection of future pharmacy service fees using the dispensing claims in hospital and clinic outpatient pharmacies: national health insurance database between 2006 and 2012.
    Ha D; Song I; Lee EK; Shin JY
    BMC Health Serv Res; 2018 May; 18(1):327. PubMed ID: 29724220
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacist home visits: A 1-year experience from a community pharmacy.
    Monte SV; Passafiume SN; Kufel WD; Comerford P; Trzewieczynski DP; Andrus K; Brody PM
    J Am Pharm Assoc (2003); 2016 Jan; 56(1):67-72. PubMed ID: 26802924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dispensing of Prescribed Medicines in Swiss Community Pharmacies-Observed Counselling Activities.
    Maes KA; Ruppanner JA; Imfeld-Isenegger TL; Hersberger KE; Lampert ML; Boeni F
    Pharmacy (Basel); 2018 Dec; 7(1):. PubMed ID: 30583485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Iowa new practice model: Advancing technician roles to increase pharmacists' time to provide patient care services.
    Andreski M; Myers M; Gainer K; Pudlo A
    J Am Pharm Assoc (2003); 2018; 58(3):268-274.e1. PubMed ID: 29606624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The influence of pharmacy and pharmacist characteristics on the secondary prevention of cardiovascular disease.
    Puspitasari HP; Aslani P; Krass I
    Int J Clin Pharm; 2015 Oct; 37(5):834-43. PubMed ID: 25964140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Payers' Perspectives on Pharmacist-Directed Care in a Community Pharmacy Setting.
    Merrill BS; Tak CR; Feehan M; Munger MA
    Ann Pharmacother; 2019 Sep; 53(9):916-921. PubMed ID: 30895798
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacists' performance of clinical interventions during adherence support medication reviews.
    Hatah E; Tordoff J; Duffull SB; Braund R
    Res Social Adm Pharm; 2014; 10(1):185-94. PubMed ID: 23688540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacy performance while providing continuous medication monitoring.
    Doucette WR; McDonough RP; Herald F; Goedken A; Funk J; Deninger MJ
    J Am Pharm Assoc (2003); 2017; 57(6):692-697. PubMed ID: 28844583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Making Value-Based Payment Work for Academic Health Centers.
    Miller HD
    Acad Med; 2015 Oct; 90(10):1294-7. PubMed ID: 26266462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Michigan's Physician Group Incentive Program offers a regional model for incremental 'fee for value' payment reform.
    Share DA; Mason MH
    Health Aff (Millwood); 2012 Sep; 31(9):1993-2001. PubMed ID: 22949448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Merit-Based Incentive Payment System: Meaningful Changes in the Final Rule Brings Cautious Optimism.
    Manchikanti L; Helm Ii S; Calodney AK; Hirsch JA
    Pain Physician; 2017; 20(1):E1-E12. PubMed ID: 28072793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What do community pharmacists do?: results from a work sampling study in London.
    Davies JE; Barber N; Taylor D
    Int J Pharm Pract; 2014 Oct; 22(5):309-18. PubMed ID: 24423212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparing the cost of community pharmacy and mail-order pharmacy in a US retirement system.
    Visaria J; Seoane-Vazquez E; Szeinbach SL; Rodriguez-Monguio R
    Int J Health Plann Manage; 2012; 27(1):e41-50. PubMed ID: 21638311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationships among prescription payment methods and interactions between community pharmacists and prescribers.
    Raisch DW
    Ann Pharmacother; 1992; 26(7-8):902-6. PubMed ID: 1504395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.